United Therapeutics Corporation (UTHR) FY2026 Q2 P&L / Income Statement

United Therapeutics Corporation (UTHR) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

783,300,000 US dollars

Cost of sales

99,500,000 US dollars

Gross profit (calculated)

683,800,000 US dollars

Operating expenses (calculated)

353,000,000 US dollars

Operating income

330,800,000 US dollars

Total other income, net

41,900,000 US dollars

Income before income taxes

372,700,000 US dollars

Income tax expense

39,700,000 US dollars

Net income

333,000,000 US dollars

UNITED STATES

733,600,000 US dollars

Non-US

49,700,000 US dollars

Research and development

146,300,000 US dollars

Selling, general, and administrative

206,700,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.